Dr. Kevin Nichols is an experienced health and diagnostics leader driving innovation in diagnostics and medical devices. He has successfully led cross-functional R&D teams, developed novel diagnostic platforms, and launched innovative products. His accomplishments include overseeing the successful integration of science functions of a diagnostics startup acquired by Amazon, developing and launching Amazon’s first diagnostic product, and leading open source COVID assay development resulting in some of the first rapid antigen tests to receive Emergency Use Authorization (EUA) in the US.
|